Hemostatic and fibrinolytic parameters in survivors of myocardial infarction: A low plasma level of plasmin-α2-antiplasmin complex is an independent predictor of coronary re-events

Blood Coagulation and Fibrinolysis

Volumn 12, Issue 1, 2001, Pages 17-24

  Redondo, M ^a   Carroll, V A ^a   Mauron, T ^a   Demarmels Biasiutti, F ^a   Binder, B R ^a   Lammle B ^a   Wuillemin, W A ^a  

^a Division of Hematology   (Switzerland)

Author keywords

Blood coagulation; Fibrinolysis; Myocardial infarction; Plasmin 2 antiplasmin; Prediction

Indexed keywords

ALPHA 2 ANTIPLASMIN; FIBRINOGEN; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE MARKER; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; FOLLOW UP; HEART INFARCTION; HEART REINFARCTION; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

ADULT; AGED; ANTIFIBRINOLYTIC AGENTS; ANTIPLASMIN; BIOLOGICAL MARKERS; BLOOD COAGULATION FACTORS; DISEASE-FREE SURVIVAL; FACTOR V; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HEMOSTATICS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLASMIN; POINT MUTATION; PROSPECTIVE STUDIES; PROTHROMBIN; RECURRENCE;

EID: 0035128987     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200101000-00003     Document Type: Article

References (31)

1. Unstable angina with fatal outcome: Dynamic coronary thrombosis leading to infarction and/or sudden death
2. Coronary angioscopy in patients with unstable angina pectoris
3. The contribution of thrombosis to the clinical expression of coronary atherosclerosis
4. The pathogenesis of coronary artery disease and the acute coronary syndromes (first of two parts)
5. The pathogenesis of coronary artery disease and the acute coronary syndromes (second of two parts)
6. Haemostatic function and ischaemic heart disease: Principle results of the Northwick Park Heart Study
7. Fibrinogen and risk of cardiovascular disease
8. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease. Meta-analyses of prospective studies
9. Fibrinolytic activation markers predict myocardial infarction in the elderly. The cardiovascular health study
10. Elevated levels of plasmin-a2-antiplasmin complexes in unstable angina
11. Prognosis and management after first myocardial infarction
12. Hemostatic factors and the risk of developing new coronary events in patients with angina pectoris: Principal results of the ECAT Angina Pectoris Study
13. Haemostatic variables and the outcome of myocardial infarction
14. Plasminogen activator inhibitor in plasma: Risk for recurrent myocardial infarction
15. Correlations between fibrinolytic function and acute myocardial infarction
16. Clinical and biochemical factors associated with prognosis after myocardial infarction at a young age
17. Fibrinogen is a predictor of mortality in coronary heart disease patients
18. Antithrombin III and fibrinogen as predictors of cardiac events in patients with angina pectoris
19. Functional characterization of an abnormal factor XII molecule (F XII Bern)
20. A quantitative dot immunobinding assay for coagulation factor XII in plasma
21. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein 'like' activity in human plasma
22. Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens
23. Hyperthermia stimulates plasminogen activator inhibitor type 1 expression in human umbilical vein endothelial cells in vitro
24. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies
25. 2-antiplasmin complexes (plasmin-plasmin inhibitor complexes)
26. Plasma protein C inhibitor is elevated in survivors of myocardial infarction
27. Mutation in blood coagulation factor V associated with resistance to activated protein C
28. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis
29. Coagulation factors II, V, VII and X, prothrombin gene 20210G → A transition and factor V Leiden in coronary artery disease: High factor V clotting activity is an independent risk factor for myocardial infarction
30. A commom genetic variation in the 3-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
31. Relationship of plasmin generation to cardiovascular disease risk factors in elderly men and women